Toxoplasma gondii infection can regulate the expression of tumour necrosis factor-α receptors on human cells in vitro

Parasite Immunology

Volumn 24, Issue 5, 2002, Pages 271-279

  Derouich Guergour, Dorra ^a   Aldebert, Delphine ^a   Vigan, Ines ^b   Jouvin Marche, Evelyne ^b   Marche, Patrice N ^b   Aubert, Dominique ^c   Ambroise Thomas, Pierre ^a   Pelloux, Hervé ^a  

^a UNIV GRENOBLE ALPES   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

ELISA; Flow cytometry; MRC5; Quantitative RT PCR; THP 1; TNF receptors; Toxoplasma gondii

Indexed keywords

MESSENGER RNA; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; TOXOPLASMA GONDII; TOXOPLASMOSIS;

PROTOZOA; TOXOPLASMA GONDII;

EID: 0036277639     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.2002.00462.x     Document Type: Article

References (57)

1. How does Toxoplasma gondii enter host cells?
2. Cell-mediated immunity to Toxoplasma gondii. initiation, regulation and effector function
3. Toxoplasmic encephalitis in AIDS
4. Toxoplasmosis: Congenital and in immunocompromised patients
5. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection
6. In the absence of endogenous interferon gamma mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection
7. Tumor necrosis factor alpha triggers antitoxoplasmal activity in gamma interferon primed macrophages
8. A protective role for endogenous TNF in Toxoplasma gondii infection
9. Immunity to Toxoplasma gondii
10. Tumor necrosis factor
11. Two different cell types have different major receptors for human tumor necrosis factor (TNFα)
12. Two TNF receptors
13. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific
14. Antiviral activity of tumor necrosis factor is signaled through the 55-kDa type I TNF receptor
15. Ligand passing: The 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor
16. Shedding of tumor necrosis factor receptors by activated human neutrophils
17. Stabilisation of the bioactivity of tumor necrosis factor by soluble receptors
18. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists
19. Purification and biologic characterisation of specific tumor necrosis factor alpha inhibitor
20. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors
21. High concentrations of soluble tumor necrosis factor receptors in ascites
22. Elevated levels of type II soluble tumor necrosis factor receptors in the bronchoalveolar lavage fluids of patients with sarcoidosis
23. Infection of murine macrophages with Toxoplasma gondii is associated with release of transforming growth factor β and downregulation of expression of tumor necrosis factor receptors
24. Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo
25. Crucial role of the TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine Toxoplasmosis
26. TNF-alpha enhances Toxoplasma gondii cyst formation in human fibroblasts through the sphingomyelinase pathway
27. Toxoplasmic encephalitis in children
28. Toxoplasma gondii: In vivo and in vitro cystogenesis of the virulent RH strain
29. A Toxoplasma gondii-derived factor(s) stimulates immune downregulation: An in vitro model
30. Toxoplasma gondii induces the secretion of monocyte chemotactic protein-1 on human fibroblasts in vitro
31. Evidence for tumor necrosis factor receptors (TNFRs) in human MRC5 fibroblast cells
32. Regulation of expression of transmembrane and soluble 75 kDa tumor necrosis factor receptors by interferon-gamma and granulocyte-macrophage colony-stimulating factor involves transcriptional activation
33. Tumor necrosis factors: Developments during the last decade
34. Mechanisms involved in the processing of the p55 and the p75 tumor necrosis factor (TNF) receptors to soluble receptor forms
35. TNF-receptors on human peritoneal mesothelial cells. Regulation of receptor levels and shedding by IL-1α and TNFα
36. Mechanism of release of soluble forms of tumor necrosis factor/lymphotoxin receptors by phorbol myristate acetate-stimulated human THP-1 cellsin vitro
37. TNF induces internalization of the p60 receptor and shedding of the p80 receptor
38. Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1
39. Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes
40. Induction of tumor necrosis factor receptor type 2 gene expression by tumor necrosis factor-α in rat primary astrocytes
41. Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55
42. Possible requirement of internalisation in the mechanism ofin vitro cytotoxicity in tumor necrosis serum
43. Tumor necrosis factor-α is required for the protective immune response against Mycobacterium tuberculosis in mice
44. -/- mice: Protection despite absence of ROI and susceptibility despite presence of RNI
45. TNFα receptors. Role in the physiopathology of protozoan parasite infections
46. Production of TNF-α, IL-6 and TGF-β and expression of receptors for TNF-, and IL-6, during murine Mycobacterium avium infection
47. Involvement of tumor necrosis factor alpha during infection of human monocytic cells by Toxoplasma gondii
48. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodonitis
49. Multifunctional regulation of the biological effects of TNFα by the soluble type 1 and type 2 TNF receptors
50. Interleukine-1, tumor necrosis factor and their specific inhibitors
51. Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of Gram-negative sepsis
52. Involvement of tumor necrosis factor alpha in intracellular multiplication of Legionelle pneumophila in human monocytes
53. Cytokine and T cell response in malaria
54. The antiviral, antitumoral xanthate D609 is a competitive inhibitor of phophatidylcholone-specific phospho-lipase C
55. Influence of cytokines on Toxoplasma gondii growth in human astrocytoma-derived cells
56. Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi